Publication

The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA

Kooij, L., Tymstra, T. & van den Berg, P., Feb-2009, In : Prenatal Diagnosis. 29, 2, p. 164-168 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

APA

Kooij, L., Tymstra, T., & van den Berg, P. (2009). The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenatal Diagnosis, 29(2), 164-168. https://doi.org/10.1002/pd.2205

Author

Kooij, Loes ; Tymstra, Tjeerd ; van den Berg, Paul. / The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. In: Prenatal Diagnosis. 2009 ; Vol. 29, No. 2. pp. 164-168.

Harvard

Kooij, L, Tymstra, T & van den Berg, P 2009, 'The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA', Prenatal Diagnosis, vol. 29, no. 2, pp. 164-168. https://doi.org/10.1002/pd.2205

Standard

The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. / Kooij, Loes; Tymstra, Tjeerd; van den Berg, Paul.

In: Prenatal Diagnosis, Vol. 29, No. 2, 02.2009, p. 164-168.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

Kooij L, Tymstra T, van den Berg P. The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenatal Diagnosis. 2009 Feb;29(2):164-168. https://doi.org/10.1002/pd.2205


BibTeX

@article{37f11789ccb442c7aefb60add0f166d5,
title = "The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA",
abstract = "Objective To determine the opinions of women about the new developments in the field of noninvasive prenatal diagnosis (NIPD).Method Prospective study using questionnaires in two groups of women: women visiting the University Medical Centre Groningen and the Martini Hospital Groningen for the routine fetal anomaly ultrasound scan at 20 weeks' gestation and female medical master students.Results Both groups consider NIPD an important asset in the reliable diagnosis of fetal aneuploidy and gender-determined genetic disorders, with the exception of disorders manifesting themselves later in life. There is a negative response as to its application for family balancing. Eighty-two percent of the pregnant women and 79% of the medical students responded positively to the question whether they consider NIPD an important asset in prenatal care. The statement that it is an asset because it enables pregnant women to bear an 'optimal child' is strongly rejected by both groups.Conclusions NIPD paves the way for screening on a large scale. Our survey shows that women feel positive about these new possibilities, but find it hard to fully realize the consequences and new choices they will be confronted with. Copyright (C) 2009 John Wiley & Sons, Ltd.",
keywords = "noninvasive prenatal diagnosis, Down syndrome, fetal DNA, maternal blood, opinion, PRENATAL-DIAGNOSIS, PLASMA, SERUM",
author = "Loes Kooij and Tjeerd Tymstra and {van den Berg}, Paul",
year = "2009",
month = feb,
doi = "10.1002/pd.2205",
language = "English",
volume = "29",
pages = "164--168",
journal = "Prenatal Diagnosis",
issn = "0197-3851",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA

AU - Kooij, Loes

AU - Tymstra, Tjeerd

AU - van den Berg, Paul

PY - 2009/2

Y1 - 2009/2

N2 - Objective To determine the opinions of women about the new developments in the field of noninvasive prenatal diagnosis (NIPD).Method Prospective study using questionnaires in two groups of women: women visiting the University Medical Centre Groningen and the Martini Hospital Groningen for the routine fetal anomaly ultrasound scan at 20 weeks' gestation and female medical master students.Results Both groups consider NIPD an important asset in the reliable diagnosis of fetal aneuploidy and gender-determined genetic disorders, with the exception of disorders manifesting themselves later in life. There is a negative response as to its application for family balancing. Eighty-two percent of the pregnant women and 79% of the medical students responded positively to the question whether they consider NIPD an important asset in prenatal care. The statement that it is an asset because it enables pregnant women to bear an 'optimal child' is strongly rejected by both groups.Conclusions NIPD paves the way for screening on a large scale. Our survey shows that women feel positive about these new possibilities, but find it hard to fully realize the consequences and new choices they will be confronted with. Copyright (C) 2009 John Wiley & Sons, Ltd.

AB - Objective To determine the opinions of women about the new developments in the field of noninvasive prenatal diagnosis (NIPD).Method Prospective study using questionnaires in two groups of women: women visiting the University Medical Centre Groningen and the Martini Hospital Groningen for the routine fetal anomaly ultrasound scan at 20 weeks' gestation and female medical master students.Results Both groups consider NIPD an important asset in the reliable diagnosis of fetal aneuploidy and gender-determined genetic disorders, with the exception of disorders manifesting themselves later in life. There is a negative response as to its application for family balancing. Eighty-two percent of the pregnant women and 79% of the medical students responded positively to the question whether they consider NIPD an important asset in prenatal care. The statement that it is an asset because it enables pregnant women to bear an 'optimal child' is strongly rejected by both groups.Conclusions NIPD paves the way for screening on a large scale. Our survey shows that women feel positive about these new possibilities, but find it hard to fully realize the consequences and new choices they will be confronted with. Copyright (C) 2009 John Wiley & Sons, Ltd.

KW - noninvasive prenatal diagnosis

KW - Down syndrome

KW - fetal DNA

KW - maternal blood

KW - opinion

KW - PRENATAL-DIAGNOSIS

KW - PLASMA

KW - SERUM

U2 - 10.1002/pd.2205

DO - 10.1002/pd.2205

M3 - Article

VL - 29

SP - 164

EP - 168

JO - Prenatal Diagnosis

JF - Prenatal Diagnosis

SN - 0197-3851

IS - 2

ER -

ID: 4853106